MedTrace Logo

Minimally Invasive Treatment Methods for Pilonidal Disease

NCT03070028 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2020-05-13

No results posted yet for this study

Summary

Patients with pilonidal sinus disease will be randomised to two groups (crystallised phenol and platelet rich plasma). Sinus healing time, patient satisfaction, complications and recurrence rates will be compared.

Conditions

  • Pilonidal Sinus

Interventions

PROCEDURE

crystallised phenol

crystallised phenol will be applied to sinus cavity

PROCEDURE

Platelet rich plasma

platelet rich plasma will be applied to sinus cavity

Sponsors & Collaborators

  • Uşak University

    lead OTHER

Principal Investigators

  • Barış Sevinç, M.D. · Uşak University Medical School

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2019-12-01
Completion
2020-05-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03070028 on ClinicalTrials.gov